DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 157 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $1,126 | -64.0% | 90,761 | -59.4% | 0.00% | -75.0% |
Q4 2023 | $3,128 | -31.4% | 223,802 | -27.5% | 0.00% | -33.3% |
Q3 2023 | $4,560 | -7.5% | 308,793 | -19.1% | 0.01% | 0.0% |
Q2 2023 | $4,930 | +11.1% | 381,618 | -15.6% | 0.01% | 0.0% |
Q1 2023 | $4,437 | -21.5% | 452,367 | -14.9% | 0.01% | -25.0% |
Q4 2022 | $5,653 | -94.9% | 531,335 | +4924.0% | 0.01% | – |
Q3 2022 | $110,000 | -51.3% | 10,576 | -41.1% | 0.00% | – |
Q2 2022 | $226,000 | -78.3% | 17,967 | -81.3% | 0.00% | -100.0% |
Q1 2022 | $1,040,000 | +44.2% | 95,978 | +87.2% | 0.00% | 0.0% |
Q4 2021 | $721,000 | +1342.0% | 51,270 | +902.2% | 0.00% | – |
Q2 2021 | $50,000 | -66.4% | 5,116 | -69.6% | 0.00% | – |
Q2 2020 | $149,000 | +292.1% | 16,814 | +150.0% | 0.00% | – |
Q4 2019 | $38,000 | -88.9% | 6,726 | -63.4% | 0.00% | -100.0% |
Q4 2017 | $343,000 | – | 18,352 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
Maven Securities LTD | 264,989 | $931,000 | 0.29% |
Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |